← Leaderboards
Ramachandran Murali
University Of Pennsylvania
$1,363,939
Attributed
$2,727,878
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $675.2K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,727,878 · 2
By mechanism
R01$2,727,878 · 1
P01$0 · 1
Top collaborators
- George Y Liu5 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- David J. Margolis$22,280,628
- Hank F Kung$16,346,808
- Elizabeth Anne Grice$13,714,585
- James Leyden$248,292
- Liselotte E Jensen$5,027,850
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneHyaluronidaseGenomicsHydrolysisAcneHyaluronanExperimental StudyEnzymesAffectGenomeAnimal ModelBiophysical TechniquesActive SitesHuman DiseaseAdolescentDisaccharidesAcne VulgarisCicatrixCollectionBaseBindingGenesCytokineImmune Response
Grant awards (6)
Pathogenic and protective roles of strain-specific P. acnes hyaluronidases in acne$479,531
R01 · FY2023 · AI · contact PI
Pathogenic and protective roles of strain-specific P. acnes hyaluronidases in acne$491,254
R01 · FY2022 · AI · contact PI
Pathogenic and protective roles of strain-specific P. acnes hyaluronidases in acne$601,122
R01 · FY2021 · AI · contact PI
Pathogenic and protective roles of strain-specific P. acnes hyaluronidases in acne$675,242
R01 · FY2020 · AI · contact PI
Pathogenic and protective roles of strain-specific P. acnes hyaluronidases in acne$480,729
R01 · FY2019 · AI · contact PI
RECEPTOR MEDIATED CANCER THERAPY$0
P01 · FY2002 · CA